CAPR - Capricor Therapeutics EPS beats by $0.06 November, 09 2021 04:09 PM Capricor Therapeutics Inc. Capricor Therapeutics (NASDAQ:CAPR): Q3 GAAP EPS of -$0.17 beats by $0.06. cash and cash equivalents balance totaled approximately $40.8M Press Release For further details see: Capricor Therapeutics EPS beats by $0.06